Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27.7M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
112
-
Shares change
-
-2.53K
-
Total reported value, excl. options
-
$1K
-
Value change
-
-$14K
-
Number of sells
-
-2
-
Price
-
$4.71
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q2 2022
4 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q2 2022.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 112 shares
of 27.7M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include FMR LLC (112 shares), Fortitude Advisory Group L.L.C. (0 shares), UBS Group AG (0 shares), HAP Trading, LLC (10K shares), Southpoint Capital Advisors LP (4.08M shares), Sonic Fund II, L.P. (2.41M shares), DG Capital Management, LLC (1.21M shares), Avoro Capital Advisors LLC (1.2M shares), Solas Capital Management, LLC (1.17M shares), and 683 Capital Management, LLC (425K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.